Ausgabe 7/2015
Inhalt (8 Artikel)
Electronic Health Data for Postmarket Surveillance: A Vision Not Realized
Thomas J. Moore, Curt D. Furberg
DNA Barcoding and Pharmacovigilance of Herbal Medicines
Hugo J. de Boer, Mihael C. Ichim, Steven G. Newmaster
The ISoP CommSIG for Improving Medicinal Product Risk Communication: A New Special Interest Group of the International Society of Pharmacovigilance
Priya Bahri, Alexander N. Dodoo, Brian D. Edwards, I. Ralph Edwards, Irene Fermont, Ulrich Hagemann, Kenneth Hartigan-Go, Bruce Hugman, Peter G. Mol
Adverse Drug Reactions and Clinical Outcomes in Patients Initiated on Antiretroviral Therapy: A Prospective Cohort Study From Ethiopia
Woldesellassie M. Bezabhe, Luke R. Bereznicki, Leanne Chalmers, Peter Gee, Desalew M. Kassie, Mekides A. Bimirew, Gregory M. Peterson
Atypical Antipsychotics and the Risk of Hyperlipidemia: A Sequence Symmetry Analysis
Yoshinori Takeuchi, Kazuhiro Kajiyama, Chieko Ishiguro, Yoshiaki Uyama
P-Glycoprotein-Mediated Drug Interactions in Pregnancy and Changes in the Risk of Congenital Anomalies: A Case-Reference Study
Aizati N. A. Daud, Jorieke E. H. Bergman, Marian K. Bakker, Hao Wang, Wilhelmina S. Kerstjens-Frederikse, Hermien E. K. de Walle, Henk Groen, Jens H. J. Bos, Eelko Hak, Bob Wilffert
Preventability of Voluntarily Reported or Trigger Tool-Identified Medication Errors in a Pediatric Institution by Information Technology: A Retrospective Cohort Study
Jeremy S. Stultz, Milap C. Nahata
Primary Care Medication Safety Surveillance with Integrated Primary and Secondary Care Electronic Health Records: A Cross-Sectional Study
Artur Akbarov, Evangelos Kontopantelis, Matthew Sperrin, Susan J. Stocks, Richard Williams, Sarah Rodgers, Anthony Avery, Iain Buchan, Darren M. Ashcroft